ReWalk Robotics (NASDAQ:LFWD) Given “Buy” Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of ReWalk Robotics (NASDAQ:LFWD) in a report published on Thursday,Benzinga reports. HC Wainwright currently has a $13.00 target price on the stock.

Separately, Laidlaw began coverage on shares of ReWalk Robotics in a research note on Monday, February 10th. They issued a “buy” rating and a $10.00 price objective for the company.

ReWalk Robotics Stock Performance

Shares of LFWD opened at $1.84 on Thursday. The company has a 50-day moving average of $1.74 and a two-hundred day moving average of $2.42. ReWalk Robotics has a one year low of $1.25 and a one year high of $7.70.

Insider Buying and Selling

In related news, major shareholder Global Fund Lp Lind II sold 381,676 shares of the business’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $3.36, for a total transaction of $1,282,431.36. Following the transaction, the insider now directly owns 1,049,430 shares of the company’s stock, valued at approximately $3,526,084.80. The trade was a 26.67 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Michael Swinford bought 21,622 shares of the business’s stock in a transaction on Monday, November 25th. The stock was bought at an average price of $2.03 per share, with a total value of $43,892.66. Following the transaction, the director now owns 65,040 shares in the company, valued at approximately $132,031.20. This represents a 49.80 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 2.50% of the company’s stock.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.